Kukjeon Pharmaceutical Co Ltd banner
K

Kukjeon Pharmaceutical Co Ltd
KOSDAQ:307750

Watchlist Manager
Kukjeon Pharmaceutical Co Ltd
KOSDAQ:307750
Watchlist
Price: 3 880 KRW -0.77%
Market Cap: ₩209.5B

Kukjeon Pharmaceutical Co Ltd
Short-Term Debt

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Kukjeon Pharmaceutical Co Ltd
Short-Term Debt Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Short-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
K
Kukjeon Pharmaceutical Co Ltd
KOSDAQ:307750
Short-Term Debt
₩8B
CAGR 3-Years
-23%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Yuhan Corp
KRX:000100
Short-Term Debt
₩199.8B
CAGR 3-Years
46%
CAGR 5-Years
33%
CAGR 10-Years
12%
SK Biopharmaceuticals Co Ltd
KRX:326030
Short-Term Debt
₩0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Hanmi Pharm Co Ltd
KRX:128940
Short-Term Debt
₩319.5B
CAGR 3-Years
-5%
CAGR 5-Years
6%
CAGR 10-Years
24%
S
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
Short-Term Debt
₩11.8B
CAGR 3-Years
62%
CAGR 5-Years
42%
CAGR 10-Years
10%
C
Caregen Co Ltd
KOSDAQ:214370
Short-Term Debt
₩0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Kukjeon Pharmaceutical Co Ltd
Glance View

Market Cap
209.5B KRW
Industry
Pharmaceuticals

Kukjeon Pharmaceutical Co., Ltd. engages in providing financial support services. The company is headquartered in Anyang, Gyeonggi-Do. The company went IPO on 2018-12-19. The firm manufactures and sells raw materials used in specialized medicines such as choline alfoscerates, benfothiamines, spherical sorbents, and napamostat mesylatse. The firm sells its products in domestic and overseas markets such as Japan.

Intrinsic Value
2 215.97 KRW
Overvaluation 43%
Intrinsic Value
Price ₩3 880
K

See Also

What is Kukjeon Pharmaceutical Co Ltd's Short-Term Debt?
Short-Term Debt
8B KRW

Based on the financial report for Sep 30, 2025, Kukjeon Pharmaceutical Co Ltd's Short-Term Debt amounts to 8B KRW.

What is Kukjeon Pharmaceutical Co Ltd's Short-Term Debt growth rate?
Short-Term Debt CAGR 3Y
-23%

Over the last year, the Short-Term Debt growth was 49%. The average annual Short-Term Debt growth rates for Kukjeon Pharmaceutical Co Ltd have been -23% over the past three years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett